Taiwan's SHL Group highlights injectable growth; Agena Bioscience opens Shanghai unit;

> Taiwan's SHL Group, a designer and manufacturer of auto and pen injectors, said its employee count has reached 3,000, reflecting strong growth in the injectable drug delivery market. Release

> U.S.-based Agena Bioscience has setup a subsidiary in Shanghai aimed at genomic testing laboratories in mainland China for its MassARRAY Systems with 60 installed on-country to date, according to a press release. The company said Bob Wang was appointed as vice president and general manager, Greater China. Release

> Japan's Pharmaceutical Medical Devices Agency has issued its latest list of precaution notices in English. The precautions cover medical devices and in vitro diagnostics for blood glucose measurements using enzymatic electrodes; small-intestinal capsule endoscope packaging; and drug-eluting coronary stent or drug-coated balloon dilatation catheter for coronary angioplasty notices. Release (PDF)

> U.S.-based DaVita Kidney Care announced a joint venture kidney care specialty hospital chain named the DaVita (Shandong) Kidney Disease Hospital in partnership with Xiaoyi Zhang, president of Shunjing Renal Hospital, the only private hospital approved for dialysis services in Jinan, the company said in a release. The company said the services include first-of-its-kind renal dialysis by a multinational health care provider and the private sector in China. Release